Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(Cyclopropylcarbonyl)piperidine-4-carboxylic acid → 4-bromo-N-[(3R,4R)-1-{[1-(cyclopropylcarbonyl)piperidin-4-yl]carbonyl}-3-(3,4-dichlorophenyl)piperidin-4-yl]-N-methylbenzamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(Cyclopropylcarbonyl)piperidine-4-carboxylic acid | HCID 8902915 | — |
| 반응물 | 4-bromo-N-[(3R,4R)-3-(3,4-dichlorophenyl)piperidin-4-yl]-N-methylbenzamide | HCID 68930105 | — |
| 생성물 | 4-bromo-N-[(3R,4R)-1-{[1-(cyclopropylcarbonyl)piperidin-4-yl]carbonyl}-3-(3,4-dichlorophenyl)piperidin-4-yl]-N-methylbenzamide | HCID 68872668 | — |
반응 단계
Using the compound obtained in Example 633, step 3 and 1-(cyclopropylcarbonyl)piperidine-4-carboxylic acid, and by the reaction and purification in the same manner as in Example 97, the title compound was obtained.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08470816B2 |
| 출처 데이터셋 | uspto-grants-2013_06 |
| ORD ID | ord-d8ef719a9da54748b36d737c5c326f56 |
| 출처 메모 | uspto-grants-2013_06 |